drugset
drugset / Trial / NCT04327934

Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome

NCT04327934 ↗

Phase 0 Terminated 28 enrolled Yale University National Heart, Lung, and Blood Institute (NHLBI) · collab
RandomizedParallel-groupOpen-labelBasic science

Summary

Women with androgen excess polycystic ovary syndrome (AE-PCOS) leads to hypertension.

Timeline

Start
2017-12-01
Primary completion
2022-06-30
Completion
2022-06-30

Outcome

Outcome not reported

Stopped (Enrollment): “Unble to complete all arms of the planned study due to Covid stoppage and difficulty with recruiting and getting enrolled participants to return post Covid.”

Drugs

EvaluationDrugModalityDoseRoute
Subject methyltestosterone Small molecule 5 mg —
Background Antagon Unknown — —

Indications

hypertensive disorder polycystic ovary syndrome